Strategic Partnerships Explore expanded distribution and co-branding opportunities with Obagi Cosmeceuticals in the US and Renellence in Canada to accelerate market access for premium aesthetics products and leverage established sales channels.

Joint Ventures Leverage the Medfile SA collaboration to combine Croma's aesthetic expertise with Medfile’s technical capabilities, creating integrated offerings for clinics and dermatology practices that enhance adoption and cross-sell ancillary products.

Product Portfolio Expansion Capitalize on recent launches of eight skincare products and the hyaluronic acid skin booster to upsell to practitioners as bundled treatments, including PRP/Fluid-PRF devices, expanding aftercare solutions and patient outcomes.

US Market Growth Target US clinics and medspas through Obagi and broader distribution networks to increase penetration of premium HA syringes, botulinum toxin, and fillers, supported by evidence-based treatment options and training.

Technology Enablement Promote digital and data-driven strategies using SAP S/4HANA, Veeva, and Microsoft 365 to streamline supply, regulatory compliance, and clinician training programs, enabling faster time-to-market and scalable field support.